title: Topiramate and fulminant liver failure.
authors.forename: K
authors.initials: K
authors.lastname: Bjøro
authors.forename: L
authors.initials: L
authors.lastname: Gjerstad
authors.forename: O
authors.initials: O
authors.lastname: Bentdal
authors.forename: S
authors.initials: S
authors.lastname: Osnes
authors.forename: E
authors.initials: E
authors.lastname: Schrumpf
mesh_terms: D000328:Adult; D000927:Anticonvulsants / Q000008:administration & dosage / Q000009:adverse effects*; D004049:Diethylcarbamazine / Q000008:administration & dosage; D004305:Dose-Response Relationship, Drug; D004347:Drug Interactions; D005260:Female; D005632:Fructose / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D006501:Hepatic Encephalopathy / Q000139:chemically induced*; D006801:Humans; D000077236:Topiramate
chemical_list: D000927:Anticonvulsants; D000077236:Topiramate; D005632:Fructose; D004049:Diethylcarbamazine